 | • レポートコード：QYR9ST04873 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、HER2抗体の世界市場について調査・分析し、HER2抗体の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（トラスツズマブ、ラパチニブ、アドトラスツズマブエムタンシン、ペルツズマブ、エベロリムス）、用途別（病院薬局、小売薬局、Eコマース）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のHER2抗体市場動向 ・主要企業別マーケットシェア ・HER2抗体の種類別市場規模2014-2019 （トラスツズマブ、ラパチニブ、アドトラスツズマブエムタンシン、ペルツズマブ、エベロリムス） ・HER2抗体の用途別市場規模2014-2019 （病院薬局、小売薬局、Eコマース） ・HER2抗体の北米市場：主要企業・種類別/用途別市場規模 ・HER2抗体のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・HER2抗体の中国市場：主要企業・種類別/用途別市場規模 ・HER2抗体の日本国内市場：主要企業・種類別/用途別市場規模 ・HER2抗体の東南アジア市場：主要企業・種類別/用途別市場規模 ・HER2抗体のインド市場：主要企業・種類別/用途別市場規模 ・HER2抗体の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Novartis、Pfizer、Roche、Abnova、InvivoGen、Celltrion、Biocon、Novus Biologicals） ・HER2抗体の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.
In 2018, the global HER2 Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global HER2 Antibodies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HER2 Antibodies development in United States, Europe and China.
The key players covered in this study
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals
Market segment by Type, the product can be split into
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
E-commerce
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global HER2 Antibodies status, future forecast, growth opportunity, key market and key players.
To present the HER2 Antibodies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of HER2 Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global HER2 Antibodies Market Size Growth Rate by Type (2014-2025)
1.4.2 Trastuzumab
1.4.3 Lapatinib
1.4.4 Ado-trastuzumab emtansine
1.4.5 Pertuzumab
1.4.6 Everolimus
1.5 Market by Application
1.5.1 Global HER2 Antibodies Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 HER2 Antibodies Market Size
2.2 HER2 Antibodies Growth Trends by Regions
2.2.1 HER2 Antibodies Market Size by Regions (2014-2025)
2.2.2 HER2 Antibodies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 HER2 Antibodies Market Size by Manufacturers
3.1.1 Global HER2 Antibodies Revenue by Manufacturers (2014-2019)
3.1.2 Global HER2 Antibodies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
3.2 HER2 Antibodies Key Players Head office and Area Served
3.3 Key Players HER2 Antibodies Product/Solution/Service
3.4 Date of Enter into HER2 Antibodies Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global HER2 Antibodies Market Size by Type (2014-2019)
4.2 Global HER2 Antibodies Market Size by Application (2014-2019)
5 United States
5.1 United States HER2 Antibodies Market Size (2014-2019)
5.2 HER2 Antibodies Key Players in United States
5.3 United States HER2 Antibodies Market Size by Type
5.4 United States HER2 Antibodies Market Size by Application
6 Europe
6.1 Europe HER2 Antibodies Market Size (2014-2019)
6.2 HER2 Antibodies Key Players in Europe
6.3 Europe HER2 Antibodies Market Size by Type
6.4 Europe HER2 Antibodies Market Size by Application
7 China
7.1 China HER2 Antibodies Market Size (2014-2019)
7.2 HER2 Antibodies Key Players in China
7.3 China HER2 Antibodies Market Size by Type
7.4 China HER2 Antibodies Market Size by Application
8 Japan
8.1 Japan HER2 Antibodies Market Size (2014-2019)
8.2 HER2 Antibodies Key Players in Japan
8.3 Japan HER2 Antibodies Market Size by Type
8.4 Japan HER2 Antibodies Market Size by Application
9 Southeast Asia
9.1 Southeast Asia HER2 Antibodies Market Size (2014-2019)
9.2 HER2 Antibodies Key Players in Southeast Asia
9.3 Southeast Asia HER2 Antibodies Market Size by Type
9.4 Southeast Asia HER2 Antibodies Market Size by Application
10 India
10.1 India HER2 Antibodies Market Size (2014-2019)
10.2 HER2 Antibodies Key Players in India
10.3 India HER2 Antibodies Market Size by Type
10.4 India HER2 Antibodies Market Size by Application
11 Central & South America
11.1 Central & South America HER2 Antibodies Market Size (2014-2019)
11.2 HER2 Antibodies Key Players in Central & South America
11.3 Central & South America HER2 Antibodies Market Size by Type
11.4 Central & South America HER2 Antibodies Market Size by Application
12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 HER2 Antibodies Introduction
12.1.4 Novartis Revenue in HER2 Antibodies Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 HER2 Antibodies Introduction
12.2.4 Pfizer Revenue in HER2 Antibodies Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 HER2 Antibodies Introduction
12.3.4 Roche Revenue in HER2 Antibodies Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Abnova
12.4.1 Abnova Company Details
12.4.2 Company Description and Business Overview
12.4.3 HER2 Antibodies Introduction
12.4.4 Abnova Revenue in HER2 Antibodies Business (2014-2019)
12.4.5 Abnova Recent Development
12.5 InvivoGen
12.5.1 InvivoGen Company Details
12.5.2 Company Description and Business Overview
12.5.3 HER2 Antibodies Introduction
12.5.4 InvivoGen Revenue in HER2 Antibodies Business (2014-2019)
12.5.5 InvivoGen Recent Development
12.6 Celltrion
12.6.1 Celltrion Company Details
12.6.2 Company Description and Business Overview
12.6.3 HER2 Antibodies Introduction
12.6.4 Celltrion Revenue in HER2 Antibodies Business (2014-2019)
12.6.5 Celltrion Recent Development
12.7 Biocon
12.7.1 Biocon Company Details
12.7.2 Company Description and Business Overview
12.7.3 HER2 Antibodies Introduction
12.7.4 Biocon Revenue in HER2 Antibodies Business (2014-2019)
12.7.5 Biocon Recent Development
12.8 Novus Biologicals
12.8.1 Novus Biologicals Company Details
12.8.2 Company Description and Business Overview
12.8.3 HER2 Antibodies Introduction
12.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2014-2019)
12.8.5 Novus Biologicals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table HER2 Antibodies Key Market Segments
Table Key Players HER2 Antibodies Covered
Table Global HER2 Antibodies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global HER2 Antibodies Market Size Market Share by Type 2014-2025
Figure Trastuzumab Figures
Table Key Players of Trastuzumab
Figure Lapatinib Figures
Table Key Players of Lapatinib
Figure Ado-trastuzumab emtansine Figures
Table Key Players of Ado-trastuzumab emtansine
Figure Pertuzumab Figures
Table Key Players of Pertuzumab
Figure Everolimus Figures
Table Key Players of Everolimus
Table Global HER2 Antibodies Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure E-commerce Case Studies
Figure HER2 Antibodies Report Years Considered
Table Global HER2 Antibodies Market Size 2014-2025 (Million US$)
Figure Global HER2 Antibodies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global HER2 Antibodies Market Size by Regions 2014-2025 (Million US$)
Table Global HER2 Antibodies Market Size by Regions 2014-2019 (Million US$)
Table Global HER2 Antibodies Market Share by Regions 2014-2019
Figure Global HER2 Antibodies Market Share by Regions 2014-2019
Figure Global HER2 Antibodies Market Share by Regions 2019
Table Market Top Trends
Table Global HER2 Antibodies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global HER2 Antibodies Market Share by Manufacturers (2014-2019)
Figure Global HER2 Antibodies Market Share by Manufacturers in 2018
Table Global HER2 Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players HER2 Antibodies Product/Solution/Service
Table Date of Enter into HER2 Antibodies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global HER2 Antibodies Market Size by Type (2014-2019) (Million US$)
Table Global HER2 Antibodies Market Size Share by Type (2014-2019)
Figure Global HER2 Antibodies Market Size Market Share by Type (2014-2019)
Table Global HER2 Antibodies Market Size by Application (2014-2019) (Million US$)
Table Global HER2 Antibodies Market Size Share by Application (2014-2019)
Figure Global HER2 Antibodies Market Size Market Share by Application (2014-2019)
Figure Global HER2 Antibodies Revenue Market Share by Application in 2018
Figure United States HER2 Antibodies Market Size 2014-2019 (Million US$)
Table United States Key Players HER2 Antibodies Revenue (2018-2019) (Million US$)
Table United States Key Players HER2 Antibodies Market Share (2018-2019)
Table United States HER2 Antibodies Market Size by Type (2014-2019) (Million US$)
Table United States HER2 Antibodies Market Share by Type (2014-2019)
Table United States HER2 Antibodies Market Size by Application (2014-2019) (Million US$)
Table United States HER2 Antibodies Market Share by Application (2014-2019)
Figure Europe HER2 Antibodies Market Size 2014-2019 (Million US$)
Table Europe Key Players HER2 Antibodies Revenue (2018-2019) (Million US$)
Table Europe Key Players HER2 Antibodies Market Share (2018-2019)
Table Europe HER2 Antibodies Market Size by Type (2014-2019) (Million US$)
Table Europe HER2 Antibodies Market Share by Type (2014-2019)
Table Europe HER2 Antibodies Market Size by Application (2014-2019) (Million US$)
Table Europe HER2 Antibodies Market Share by Application (2014-2019)
Figure China HER2 Antibodies Market Size 2014-2019 (Million US$)
Table China Key Players HER2 Antibodies Revenue (2018-2019) (Million US$)
Table China Key Players HER2 Antibodies Market Share (2018-2019)
Table China HER2 Antibodies Market Size by Type (2014-20189) (Million US$)
Table China HER2 Antibodies Market Share by Type (2014-2019)
Table China HER2 Antibodies Market Size by Application (2014-2019) (Million US$)
Table China HER2 Antibodies Market Share by Application (2014-2019)
Figure Japan HER2 Antibodies Market Size 2014-2019 (Million US$)
Table Japan Key Players HER2 Antibodies Revenue (2018-2019) (Million US$)
Table Japan Key Players HER2 Antibodies Market Share (2018-2019)
Table Japan HER2 Antibodies Market Size by Type (2014-2019) (Million US$)
Table Japan HER2 Antibodies Market Share by Type (2014-2019)
Table Japan HER2 Antibodies Market Size by Application (2014-2019) (Million US$)
Table Japan HER2 Antibodies Market Share by Application (2014-2019)
Figure Southeast Asia HER2 Antibodies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players HER2 Antibodies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players HER2 Antibodies Market Share (2018-2019)
Table Southeast Asia HER2 Antibodies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia HER2 Antibodies Market Share by Type (2014-2019)
Table Southeast Asia HER2 Antibodies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia HER2 Antibodies Market Share by Application (2014-2019)
Figure India HER2 Antibodies Market Size 2014-2019 (Million US$)
Table India Key Players HER2 Antibodies Revenue (2018-2019) (Million US$)
Table India Key Players HER2 Antibodies Market Share (2018-2019)
Table India HER2 Antibodies Market Size by Type (2014-2019) (Million US$)
Table India HER2 Antibodies Market Share by Type (2014-2019)
Table India HER2 Antibodies Market Size by Application (2014-2019) (Million US$)
Table India HER2 Antibodies Market Share by Application (2014-2019)
Figure Central & South America HER2 Antibodies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players HER2 Antibodies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players HER2 Antibodies Market Share (2018-2019)
Table Central & South America HER2 Antibodies Market Size by Type (2014-2019) (Million US$)
Table Central & South America HER2 Antibodies Market Share by Type (2014-2019)
Table Central & South America HER2 Antibodies Market Size by Application (2014-2019) (Million US$)
Table Central & South America HER2 Antibodies Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in HER2 Antibodies Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in HER2 Antibodies Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in HER2 Antibodies Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in HER2 Antibodies Business (2014-2019)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Revenue in HER2 Antibodies Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in HER2 Antibodies Business (2014-2019)
Table Roche Recent Development
Table Abnova Company Details
Table Abnova Revenue in HER2 Antibodies Business (2014-2019)(Million US$)
Figure Abnova Revenue Growth Rate in HER2 Antibodies Business (2014-2019)
Table Abnova Recent Development
Table InvivoGen Company Details
Table InvivoGen Revenue in HER2 Antibodies Business (2014-2019)(Million US$)
Figure InvivoGen Revenue Growth Rate in HER2 Antibodies Business (2014-2019)
Table InvivoGen Recent Development
Table Celltrion Company Details
Table Celltrion Revenue in HER2 Antibodies Business (2014-2019)(Million US$)
Figure Celltrion Revenue Growth Rate in HER2 Antibodies Business (2014-2019)
Table Celltrion Recent Development
Table Biocon Company Details
Table Biocon Revenue in HER2 Antibodies Business (2014-2019)(Million US$)
Figure Biocon Revenue Growth Rate in HER2 Antibodies Business (2014-2019)
Table Biocon Recent Development
Table Novus Biologicals Company Details
Table Novus Biologicals Revenue in HER2 Antibodies Business (2014-2019)(Million US$)
Figure Novus Biologicals Revenue Growth Rate in HER2 Antibodies Business (2014-2019)
Table Novus Biologicals Recent Development
Table Global HER2 Antibodies Market Size by Regions (Million US$) 2019-2025
Figure Global HER2 Antibodies Market Size Share by Regions (2019-2025)
Figure Global HER2 Antibodies Market Size Share by Regions in 2025
Figure United States HER2 Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Europe HER2 Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure China HER2 Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Japan HER2 Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia HER2 Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure India HER2 Antibodies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America HER2 Antibodies Market Size Forecast (2019-2025)(Million USD)
Table Global HER2 Antibodies Market Size by Product (2019-2025) (Million US$)
Figure Global HER2 Antibodies Market Size by Product (2019-2025)
Figure Global HER2 Antibodies Market Size by Product in 2025
Table Global HER2 Antibodies Market Size by Application (2019-2025) (Million US$)
Figure Global HER2 Antibodies Market Size by Application (2019-2025)
Figure Global HER2 Antibodies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
HER2陰性乳癌治療の世界市場：市場規模・現状・予測 HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein.In 2018, the global HER2-negative breast cancer Treatment mar…- 乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…
- ナノ抗体の世界市場：市場規模・現状・予測 Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages: Small size (~15kd) High affinity (frequently nanomolar range) High specificity Unsurpa…
- 世界のバイオシミラーモノクローナル抗体市場：専門的調査 Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are calle…
- 神経科抗体及びアッセイの世界市場：市場規模・現状・予測 The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.In 2018, the global Neuroscience Antibodies and Assays market size was…